ArticleNature communications2025

Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer.

Jingxin Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.